Angiotensin-Converting Enzyme 3D structures: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 14: | Line 14: | ||
*Angiotensin Converting Enzyme N domain (1-641) complex | *Angiotensin Converting Enzyme N domain (1-641) complex | ||
**[[6zpq]], [[6zpt]] - hANCE (mutant) <br /> | |||
**[[2c6n]], [[1o86]], [[4c2p]], [[2ydm]], [[1uze]], [[1uzf]], [[6h5x]] - hANCE + anti-hypertensive drug<br /> | **[[2c6n]], [[1o86]], [[4c2p]], [[2ydm]], [[1uze]], [[1uzf]], [[6h5x]] - hANCE + anti-hypertensive drug<br /> | ||
**[[6en5]], [[6en6]], [[4bzr]], [[6tt4]] - hANCE + inhibitor<br /> | **[[6en5]], [[6en6]], [[4bzr]], [[6tt4]] - hANCE + inhibitor<br /> | ||
| Line 19: | Line 20: | ||
**[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE + chronic heart failure drug<br /> | **[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE + chronic heart failure drug<br /> | ||
**[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]], [[6cs2]], [[6acg]], [[6acj]], [[6ack]], [[6lzg]], [[6m0j]], [[6vw1]] – hANCE 2 + spike glycoprotein<br /> | **[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]], [[6cs2]], [[6acg]], [[6acj]], [[6ack]], [[6lzg]], [[6m0j]], [[6vw1]] – hANCE 2 + spike glycoprotein<br /> | ||
**[[7a91]], [[7a92]], [[7a94]], [[7a95]], [7a96]], [[7a97]], [[7a98]], [[7bh9]], [[7ct5]], [[7df4]], [[7kj2]], [[7kj3]], [[7kj4]], [[7kmb]], [[7kms]], [[7kmz]], [[7knb]], [[7kne]], [[7knh]], [[7kni]], [[7l7f]] – hANCE 2 + SARS-Cov-2 spike glycoprotein – Cryo EM<br /> | |||
**[[7dmu]] – hANCE 2 (mutant) + SARS-Cov-2 spike glycoprotein <br /> | |||
**[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE + phosphinic inhibitor<br /> | **[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE + phosphinic inhibitor<br /> | ||
**[[4ca6]], [[6tt1]] - hANCE | **[[4ca6]], [[6tt1]] - hANCE (mutant) + phosphinic inhibitor<br /> | ||
**[[4aph]] – hANCE + angiotensin II<br /> | **[[4aph]] – hANCE + angiotensin II<br /> | ||
**[[4apj]], [[6qs1]] – hANCE + bradykinin-potentiating peptide B<br /> | **[[4apj]], [[6qs1]] – hANCE + bradykinin-potentiating peptide B<br /> | ||
**[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | **[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | ||
**[[7c8d]] – ANCE + SARS-Cov-2 spike glycoprotein – cat - Cryo EM<br /> | |||
**[[7c8k]] – baANCE – bat - Cryo EM<br /> | |||
**[[7c8j]] – baANCE + SARS-Cov-2 spike glycoprotein<br /> | |||
**[[2xhm]] – DmANCE+K inhibitor<br /> | **[[2xhm]] – DmANCE+K inhibitor<br /> | ||
**[[2x8z]], [[2x90]], [[2x91]], [[2x92]], [[2x93]], [[2x94]], [[2x95]], [[2x96]], [[2x97]], [[1j36]], [[1j37]], [[1j38]], [[3zqz]] – DmANCE+anti-hypertensive drug<br /> | **[[2x8z]], [[2x90]], [[2x91]], [[2x92]], [[2x93]], [[2x94]], [[2x95]], [[2x96]], [[2x97]], [[1j36]], [[1j37]], [[1j38]], [[3zqz]] – DmANCE+anti-hypertensive drug<br /> | ||
| Line 31: | Line 37: | ||
**[[6s1z]] – moANCE + fosinoprilat<br /> | **[[6s1z]] – moANCE + fosinoprilat<br /> | ||
*Angiotensin Converting Enzyme C domain (642-1232) | *Angiotensin Converting Enzyme C domain (642-1232) | ||
**[[6zpu]] – hANCE 1<br /> | |||
**[[3l3n]] – hANCE+LISW<br /> | **[[3l3n]] – hANCE+LISW<br /> | ||
**[[3bkk]], [[3bkl]] – hANCE+ketone inhibitor<br /> | **[[3bkk]], [[3bkl]] – hANCE+ketone inhibitor<br /> | ||